Cargando…
Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks
BACKGROUND: Ciclosporin and oclacitinib are immunomodulators approved for the treatment of canine atopic dermatitis. The administration of a short course of prednisolone at the beginning of ciclosporin therapy hastens the efficacy of this drug; oclacitinib has a rapid antipruritic effect similar to...
Autores principales: | Panteri, Alessandro, Strehlau, Günther, Helbig, Rainer, Prost, Christine, Doucette, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737300/ https://www.ncbi.nlm.nih.gov/pubmed/26660461 http://dx.doi.org/10.1111/vde.12278 |
Ejemplares similares
-
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs
por: Little, Peter R, et al.
Publicado: (2015) -
Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis
por: Cosgrove, Sallie B, et al.
Publicado: (2013) -
A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis
por: Cosgrove, Sallie B., et al.
Publicado: (2013) -
Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia
por: Gadeyne, Caroline, et al.
Publicado: (2014) -
Comparative study to evaluate the voluntary acceptance of two liquid oral formulations of ciclosporin in dogs
por: Kammanadiminti, Srinivas J., et al.
Publicado: (2018)